Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.
Am J Obstet Gynecol. 2011 Jun;204(6):496.e1-6. doi: 10.1016/j.ajog.2011.02.018. Epub 2011 Apr 14.
Many fibroids regress with pregnancy or postpartum involution. We sought to identify factors that might inhibit or enhance this natural regression.
We used a prospective cohort of women with fibroids (n = 494) determined by ultrasound screening during the early first trimester identified from the Right from the Start study. Ultrasounds were repeated 3-6 months postpartum (n = 279). Logistic regression analyses were used to identify factors associated with fibroid regression (>50% reduction in volume).
Postpartum progestin users had significantly less fibroid regression (P = .01), whereas there was no association for combined estrogen-progestin use. Cesarean delivery and fever (hypothesized to inhibit regression) and breast feeding (hypothesized to enhance regression) were not associated with fibroid regression.
Progestin use in the postpartum period may limit regression of fibroids, consistent with prior literature on progesterone's role in fibroid development. Research into progestin-only treatments in critical reproductive periods is needed.
许多子宫肌瘤在怀孕或产后退化。我们试图确定可能抑制或增强这种自然退化的因素。
我们使用前瞻性队列研究的方法,对早期妊娠第一孕期通过超声筛查确定的子宫肌瘤患者(n = 494)进行研究,该研究来自 Right from the Start 研究。产后 3-6 个月重复超声检查(n = 279)。采用逻辑回归分析确定与肌瘤退化(体积减少>50%)相关的因素。
产后孕激素使用者的子宫肌瘤退化明显减少(P =.01),而联合使用雌激素-孕激素则没有关联。剖宫产分娩和发热(假设抑制退化)以及母乳喂养(假设促进退化)与子宫肌瘤退化无关。
产后孕激素的使用可能会限制子宫肌瘤的退化,这与孕激素在子宫肌瘤发展中的作用的先前文献一致。需要研究在关键生殖期孕激素的单一疗法。